Sitemap

Pages

• Contact
• Grievances & Complaints
• News
• Home
• Contact
• News

Top Level Pages

• About
• Careers
• Partners
• Portfolio
• Programs

General Pages

• Accessibility
• Global Health Security Portfolio
• Catalytic Health Investment Platform (CHIP)
• Frontier Fund
• Global Health Investment Fund
• Message Sent
• Privacy

News

• GHIC launches the Frontier Fund to seed new innovations to develop novel medical countermeasures
• GHIC Invests in Cytovale’s $100 Million Series D to Accelerate Commercial Expansion of its Rapid Sepsis Solution
• GHIC invests in AfricInvest's Transform Health Fund through the newly launched Catalytic Health Investment Platform
• GHIC and KfW launch Catalytic Health Investment Platform
• GHIC Invests in Cytovale’s Series C Financing
• GHIC Receives $100 million from BARDA toward Project NextGen goals
• GHIC - BARDA Ventures Year 2 Partnership Report
• CEPI and GHIC Collaborate to Advance Vaccine R&D for Emerging Infectious Diseases
• GHIC Adds Micron Biomedical to Global Health Security Portfolio
• GHIC Co-Leads Centivax Seed Round
• GHIC Invests in Vaxess Technologies' Series B Financing
• GHIC Adds Univercells to Global Health Security Portfolio
• GHIC Receives Additional $53M from BARDA
• GHIC Invests in Monod Bio's Seed Financing
• GHIC Adds Endpoint Health to Global Health Security Portfolio
• GHIC Receives Additional BARDA Funding
• GHIC and MITRE Launch Strategic Partnership
• GHIC Makes Anchor Investment in the Launch of the Women’s and Children’s Health Technology Fund
• GHIC Makes Initial Global Health Security Portfolio Investment Following the Launch of its BARDA Partnership
• GHIC Receives Initial Funding from BARDA
• Merck spinoff Organon completes acquisition of GHIF portfolio company Alydia Health
• GHIC Announces Partnership with the US Government to Promote Global Health Security